Transseptal Solutions Ltd.

www.transseptalsolutions.com

High-Tech Company

TECH VERTICALS

Cardiology, Healthtech, Life Sciences, Medical Devices, MedTech, Surgery

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	2013
Number of Employees	15
Reg. Number:	abCDe

DESCRIPTION

Transseptal Solutions in collaboration with leading clinicians, researchers, and scientists worldwide, brings to the market a new steerable sheath with a novel approach of transseptal puncture and left atrial navigation, all in one system. By addressing significant unmet market needs, Transseptal Solutions seeks to improve the LA access procedure and generate an innovative approach to serve the expanding indications of left heart treatment.

TECHNOLOGY

TSP Crosser System for Transseptal Access and Left Atrial Catheter Navigation.

Transseptal Puncture, Mitral Valve Repair, EP Ablation Treatments, LAA Appendage Closure, Transcatheter Left Atrium Procedures, Flexible Needle, Steerable Sheath.

Products and Phases

Product	Phase
TSP Crosser	FDA Approved CE Approved
The TSP Crosser (CE marked & FDA approved ) is an integrated transseptal system that includes an innovative method to engage the fossa ovalis precisely and efficiently using an extendable radiopaque loop wire, and a steerable sheath to precisely navigate a flexible needle for accurate and optimal left atrial (LA) access. After the puncture, the steerable sheath serves as a guiding catheter for left side procedures: Transcatheter Mitral Repair/Replacement; PVL closure; Atrial fibrillation ablation; LAA occlusion.

	TARGET MARKETS
	Cardiologists, Medical Centers, Healthcare Providers

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Netanya, Israel

Address	10 HaGavish St.
City	Netanya
Country	Israel
Zip	4214001

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Elad Sapir	CEO & Founder	Expanding Orthopedics (VP, Clinical Support)
Mr. Eyal Teichman	CTO & Chief Engineer	MedGenesis (VP, R&D)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Owner, Rainbow Medical
abC Defghij	Board Member	Chair of Cardiovascular Surgery, University Hospital Zurich
abC Defghij	Board Member	N\A
abC Defghij	Board Member	N\A

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

Jan. 01, 2014

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Last Updated:	abCDe
IVC Number:	abCDe